SCHEMBL8779218

SCHEMBL8779218

O=C(O)c1cc(C(=O)O)cc(-c2ccc(Cl)cc2Cl)c1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 3/20 0.68
AHR P35869 1/20 0.55
MARS1 P56192 7/20 0.54
ALPL P05186 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.50
TSHR P16473 2/20 0.50
ALDH1A1 P00352 1/20 0.50
TP53 P04637 1/20 0.50
KDM4E B2RXH2 1/20 0.50
NPC1 O15118 1/20 0.50
CRHBP P24387 1/20 0.50
RAB9A P51151 1/20 0.50
CRHR2 Q13324 1/20 0.50
CASP1 P29466 1/20 0.50
SRD5A1 P18405 1/20 0.49
ALOX15 P16050 1/20 0.47
TPMT P51580 1/20 0.47
AURKA O14965 1/20 0.45
TPX2 Q9ULW0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biguanide SCHEMBL8619381 0.87 SRD5A2 (0.54) SRD5A2AHRMARS1ALPLSMN1; SMN2
SCHEMBL444367 0.85 SRD5A2 (0.90) SRD5A2MARS1SMN1; SMN2TSHRALDH1A1
SCHEMBL442436 0.84 SRD5A2 (0.62) SRD5A2MARS1NPC1RAB9A
SCHEMBL2408930 0.80 CA1 (0.56) SRD5A2SMN1; SMN2TSHRALDH1A1TP53
SCHEMBL2908235 0.80 NOTUM (0.66) SRD5A2AHRMARS1ALPLSMN1; SMN2
SCHEMBL30069186 0.80 NOTUM (0.66) SRD5A2AHRMARS1ALPLSMN1; SMN2
SCHEMBL15124553 0.79 CYP2A6 (0.54) ALPLSMN1; SMN2TSHRALDH1A1KDM4E
SCHEMBL3653446 0.79 MARS1 (0.49) SRD5A2AHRMARS1ALPLSMN1; SMN2
SCHEMBL358511 0.78 SRD5A2 (0.48) SRD5A2MARS1ALPLSMN1; SMN2KDM4E
SCHEMBL2715026 0.78 SRD5A2 (0.48) SRD5A2MARS1ALPLSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0774457-A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-21 EP disclosed